GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Haisco Pharmaceutical Group Co Ltd (SZSE:002653) » Definitions » Forward Dividend Yield %

Haisco Pharmaceutical Group Co (SZSE:002653) Forward Dividend Yield % : 0.65% (As of Jun. 02, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Haisco Pharmaceutical Group Co Forward Dividend Yield %?

As of today (2024-06-02), the Forward Annual Dividend Yield of Haisco Pharmaceutical Group Co is 0.65%.

As of today (2024-06-02), the Trailing Annual Dividend Yield of Haisco Pharmaceutical Group Co is 0.65%.

SZSE:002653's Forward Dividend Yield % is ranked worse than
79.22% of 154 companies
in the Biotechnology industry
Industry Median: 1.57 vs SZSE:002653: 0.65

Haisco Pharmaceutical Group Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Haisco Pharmaceutical Group Co's average Dividends Per Share Growth Rate was -100.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Haisco Pharmaceutical Group Co was 22.50% per year. The lowest was -41.50% per year. And the median was -2.15% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Haisco Pharmaceutical Group Co's Forward Dividend Yield %

For the Biotechnology subindustry, Haisco Pharmaceutical Group Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haisco Pharmaceutical Group Co's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haisco Pharmaceutical Group Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Haisco Pharmaceutical Group Co's Forward Dividend Yield % falls into.



Haisco Pharmaceutical Group Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Haisco Pharmaceutical Group Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.2000002024-05-242024-05-232024-05-24Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Haisco Pharmaceutical Group Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.2/30.64
=0.65 %

Current Share Price is ¥30.64.
Haisco Pharmaceutical Group Co's Dividends per Share for the forward twelve months is calculated as ¥0.2 * 1 = ¥0.2.

Haisco Pharmaceutical Group Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.2/30.64
=0.65 %

Current Share Price is ¥30.64.
Haisco Pharmaceutical Group Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.2.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haisco Pharmaceutical Group Co  (SZSE:002653) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Haisco Pharmaceutical Group Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Haisco Pharmaceutical Group Co (SZSE:002653) Business Description

Traded in Other Exchanges
N/A
Address
No. 17, Sanxiang Avenue, Shannan District, Tibet Autonomous Region, Zetang, CHN, 856000
Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.
Executives
Fan Xiu Lian Directors, executives
Zheng Wei Directors, executives
Wang Meng Secretary Dong
Wang Jun Min Directors, executives
Deng Xiang Directors, executives
Liu Han Bing Supervisors
Zhang Xiao Xu Supervisors
Tan Hong Executives
Shen Ping Director
Liang Yong Supervisors
Chen Long Independent director
Duan Qing Liang Supervisors

Haisco Pharmaceutical Group Co (SZSE:002653) Headlines

No Headlines